Posters

Neuroprotective treatment of patients with primary open-angle glaucoma

Poster Details

First Author: N.Yangieva UZBEKISTAN

Co Author(s):    D. Tuychibayeva                    

Abstract Details

Purpose:

Investigation of neuro-protective efficacy of complex treatment combined with Ronocite  in primary open angle glaucoma with normal intraocular pressure level basing on clinical and functional evaluation of visual organs indices.

Setting:

Tashkent State Dental Institute.

Methods:

Sixty patients  aged 60,75± 12,83 years, on the average, with POAG. All the patients were subdivided  into 2 groups: main  and control ones. The control group included 28 patients (47 eyes),  they were treated by  traditional methods. The main group (32 patient 58 eyes) was treated by the traditional therapy combined with Ronocite. All patients underwent: visometry with the best correction, biomicroscopy, gonioscopy, computer perimeter on Humphrey vision field analyzer (HFA II 740), tonography, examination of the fundus with a VOLK lens, optical coherence tomography (OCT).

Results:

Treatment of patients with POAG by the recommended scheme has demonstrated reliable improvement in visual acuity to 0,08-0,2, being 4 times higher if compared to that by the traditional therapy. The patients of the main group with POAG shaved reliable improvement of CFFPD indices: to 14,5% at I stage, to 13,9% - II stage, and in the control group to 2,7 and 2,4%, on the average, respectively. Rinocite provides more marked neuro-protective effect in POAG by rendering  the nerve tissue effective deference and delaying the apoptosis.

Conclusions:

Analysis of the obtained results  indicated the high enough clinical effect of Ronocite (citicolinum)  used for the conservative treatment of  patients with the POAG with compensative IOP.

Financial Disclosure:

None